NEW YORK (GenomeWeb) – Curetis announced today that it has signed collaboration and commercialization deals with BGI Group subsidiary MGI to combine their technologies for next-generation sequencing-based infectious disease testing.

The firms said they plan to combine Curetis' Unyvero Lysator-based sample preparation technology and MGI's NGS to create a fully automated workflow that allows for the processing of any type of native clinical sample, with the subsequent NGS-based detection of microbial pathogens and genetic markers for antibiotic resistance. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.